Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmos (PARS) -- Ignore unavailable to you. Want to Upgrade?

To: johnny weissman who wrote (814)	6/3/1999 10:54:00 AM
From: cm	Respond to of 1386

Wow, Johnny, You Said A Mouthful... I would politely suggest that you will, in fact, dine on your words some day. That's my prediction, for whatever its worth. I think the under-performance of the stock is traceable to several factors that have been hashed and re-hashed: predatory financing (that's my opinion, at least), small caps out of favor (until fairly recently, according to a NYT article yesterday), the biotech bust and lingering post-bust animosities, lack of analyst coverage, etc. But, I am not here to offer excuses for a bad stock. I am just thankful that, with the possible exception of the predatory financing (a shot-gun marriage, at best), no one has to make excuses for a bad company. 'Cause the company (products, research, people) ain't bad. Far from it. As for the "penny stock" reference... and the thing about the company should have never gone public to begin with... well... if I didn't know better, I'd say that's classic shorter speak. But, I'll give you the benefit of the doubt. Not that you need my indulgence. I'm guessing that you're just frustrated. And that's completely understandable. But, I'm about to add another 10,000 shares. I suppose, that would make me a dreamer or a fool in your book. But, I am confident enough in my own DD and that of others to keep right on buying. (I sure hope that Dimensional Fund Advisors does the same, by the way.) The wait is punishing. But, my retirement party isn't for another fifteen years or so anyway. Best Regards and Courage To Fellow PARSians, c m

To: johnny weissman who wrote (814)	6/3/1999 10:59:00 AM
From: yosi s	Respond to of 1386

Pharmos is a biotech company, They go public to raise money to advance their science. To date they where able to bring products to market. Those product will give Pharmos the cash flow it needs. That will occur year end -early 2000. Not bad for a biotech where most company fail on the way. Each market segments carry its own risk and reward ratio. Most internet stock are yet to make a profit. The sector is hot. Just like biotech promise was in the past. Now biotech are bringing products to market.

To: johnny weissman who wrote (814)	6/3/1999 11:29:00 PM
From: LemonHead	Read Replies (1) \| Respond to of 1386

Only a very few people will ever benefit from PARS being a public company. Funny thing is that you have so many shares out there, dilution seams to be never ending. I can't help but think that even though you have some progress with product, research and profitability, there is really some underlining dark hoarse that is never discussed. I feel that their is this constant manipulation with the shorting. I swear I see the pattern with the posts here on SI. Is it a fabrication of my mind, or is it obvious to others? Keith

To: johnny weissman who wrote (814)	6/5/1999 8:38:00 AM
From: LLCF	Respond to of 1386

< Only a buy-out can jack this stock up, imo> There is one other way... profits, or the obvious conclusion that they will have them... that has not happend yet [to the public]... even when HU gets partnered, I don't think it will be a foregone conclusion for everyone that profits will be next. When and if profits start getting put into the valuation model by people looking at this stock, forget it, it will skyrocket IMO. By the way... I think it's a bit naive to think that analysts havent seen this stock... it's on everyones comprehensive list of the biotech universe. DAK